Develops a hybrid deep learning model for accurate ocular disease diagnosis, suggesting significant improvements in precision and deployment.
Automated ocular disease diagnosis faces critical challenges including insufficient diagnostic precision, local–global feature imbalance, rigid feature fusion, weak cross-domain generalization, and difficult lightweight deployment. This study aims to develop a high-performance, generalizable, and deployable hybrid deep learning architecture for accurate multi-class ocular disease diagnosis. We propose the Res101-MViT-Ens hybrid architecture, which fuses ResNet101 for local fine-grained feature extraction and MobileViT-XXS for global contextual modeling via an end-to-end dynamic learnable weight fusion mechanism, with class-balanced sampling and medically adaptive augmentation for data preprocessing. The model is validated on the ODIR-5K dataset and cross-evaluated on three heterogeneous datasets (MESSIDOR-2, Kaggle DR, EyePACS). It achieves 99.44% accuracy, a 99.41% F1-score, and 99.32% Kappa on ODIR-5K, with a 99.46% average cross-dataset accuracy, outperforming state-of-the-art models. With 54 M parameters and 42.6 ms per-image inference latency on the Snapdragon 8 Gen2 edge module (Qualcomm Technologies, Inc., San Diego, CA, USA), it outperforms mainstream edge architectures. This proposed architecture achieves state-of-the-art diagnostic precision; balances accuracy, generalization and practicality; and is suitable for lightweight grassroots deployment in ocular disease screening.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: